Developing IP Strategy for FDA-Regulated Drug Products Requires Special Considerations
More Than Your Mark
FEBRUARY 11, 2019
Despite the widely diverging needs of the different industries that make use of the US patent system, US patent law applies essentially the same rules to innovations from all technology fields. This means that drug and biotechnology-based inventions are treated no differently by the U.S. Patent and Trademark Office (USPTO) as inventions in fields such as computer science, information technology, household consumer products, financial services, and industrial chemicals, etc.
52 
Let's personalize your content